Gloucestershire Hospitals
Association
Location:
Gloucester,
United Kingdom (GB)
ISNI: 000000040387634X
ROR: https://ror.org/04mw34986
Colorectal dysplasia in chronic inflammatory bowel disease: a contemporary consensus classification and interobserver study (2023)
Harpaz N, Goldblum JR, Shepherd NA, Riddell RH, Rubio CA, Vieth M, Wang HH, Odze RD
Journal article
Brachytherapy training survey among radiation oncology residents in Europe (2022)
Sturdza AE, Stephanides M, Jurgenliemk-Schulz I, Eriksen JG, Benstead K, Hoskin P, Vlad S, et al.
Journal article
Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma (2021)
Dighe SG, Chen J, Yan L, He Q, Gharahkhani P, Onstad L, Levine DM, et al.
Journal article
Multicenter cohort study of patients with buried bumper syndrome treated endoscopically with a novel, dedicated device (2021)
Costa D, Despott EJ, Lazaridis N, Woodward J, Kohout P, Rath T, Scovell L, et al.
Journal article
Comparability of Raman Spectroscopic Configurations: A Large Scale Cross-Laboratory Study (2020)
Guo S, Beleites C, Neugebauer U, Abalde-Cela S, Afseth NK, Alsamad F, Anand S, et al.
Journal article
THE NOX1/4 INHIBITOR GKT831 ACHIEVES CLINICALLY MEANINGFUL REDUCTIONS IN LIVER STIFFNESS, ATTENUATES CHOLESTASIS, AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (2019)
Huang JC, Invernizzi P, Dalekos GN, Nevens F, Van Vlierberghe H, Zigmond E, Andrade RJ, et al.
Conference contribution
Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial (2019)
Dalekos G, Invernizzi P, Nevens F, Hans VV, Zigmond E, Andrade RJ, Ben Ari Z, et al.
Conference contribution